Clinical Evidence


Delve into clinical research studies and more 

Clinical research lies at the heart of who we are. Vantive uses scientific evidence systematically and transparently, to inform the development of state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Vantive.

254 results

HDx therapy enabled by Theranova
The Rationale for Expanded Hemodialysis Therapy (HDx)
HDx therapy enabled by Theranova
The real-life study on expanded hemodialysis (HDx): 9 months experience of a single hemodialysis unit
HDx therapy enabled by Theranova
The Rise of Expanded Hemodialysis
HDx therapy enabled by Theranova
The use of medium cutoff dialyzers in patients with multiple myeloma and acute kidney injury requiring hemodialysis: A systematic review
HDx therapy enabled by Theranova
Theranova versus FX80: The impact on anemia management in hemodialysis.
PD
Trends in outcomes for an automated peritoneal dialysis program with and without remote management in Columbia - Sanabria M, et al.
HDx therapy enabled by Theranova
Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with online hemodiafiltration
HDx therapy enabled by Theranova
UK Clinical Experiences of a New Expanded Hemodialysis Therapy with a Novel Medium Cut-Off Dialyzer
HDx therapy enabled by Theranova
Updates on hemodialysis techniques with a common denominator: The personalization of the dialytic therapy.
HDx therapy enabled by Theranova
Uremia Retention Molecules and Clinical Outcomes
HDx therapy enabled by Theranova
Use of regional citrate anticoagulation with medium cut-off membrane: pilot report
HDx therapy enabled by Theranova
Water saving comparison at different dialysate flows in expanded hemodialysis

Vantive is a trademark of Vantive Health LLC or its affiliates.